Kevin Ali - May 1, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Executive Officer, Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Stock symbol
OGN
Transactions as of
May 1, 2023
Transactions value $
-$36,723
Form type
4
Date filed
5/3/2023, 07:05 PM
Previous filing
Apr 4, 2023
Next filing
May 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +2.71K +6.86% 42.2K May 1, 2023 Direct F1
transaction OGN Common Stock Tax liability -$36.7K -1.49K -3.53% $24.63 40.7K May 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -2.71K -100% $0.00 0 May 1, 2023 Common Stock 2.71K Direct F1

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested.